0:45
Impact of fcRn inhibitors on IgG-mediated autoimmune disorders
James F. Howard Jr.
• 7 Apr 2021
4:59
ADAPT analysis: efgartigimod for generalized myasthenia gravis
James F. Howard Jr.
• 7 Apr 2021